FDA Adverse Event Injury Summary report: N

RX ACCULINK CAROTID STENT SYSTEM

MDR report key: 1726133 · Received June 15, 2010

Report

Report Number
3004742046-2010-00255
Event Type
Injury
Date Received
June 15, 2010
Date of Event
May 12, 2010
Report Date
May 21, 2010
Manufacturer
ABBOTT VASCULAR-VASCULAR SOLUTIONS
Product Code
NIM
PMA / PMN Number
P040038
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B) (4). (B) (4). IT IS POSSIBLE THAT THE STENT JUMPED OR INACCURATE PLACEMENT MAY BE A RESULTS OF, BUT NOT LIMITED TO, PT'S VESSEL GEOMETRY OR THE VESSEL DIAMETER WHICH COULD HAVE BEEN LARGER THAN THE STENT OR WHEN THE STENT DOES NOT APPOSE THE VESSEL WALL WHEN THE STENT IS FULLY DEPLOYED, AND WHEN THERE IS INADVERTENT MOVEMENT OF THE HANDLING DURING DEPLOYMENT OR THE POSITIONING OF THE STENT PRIOR TO DEPLOYMENT WAS NOT OPTIMAL. FURTHERMORE, THE ACCULINK INSTRUCTION FOR USE NOTES, UNDER STENT DEPLOYMENT CAUTION, THAT PRIOR TO STENT DEPLOYMENT, REMOVE ALL SLACK FROM THE DELIVERY SYSTEM. BASED ON AVAILABLE INFO AND WITHOUT THE PRODUCT BEING RETURNED FOR ANALYSIS, A DEFINITIVE CAUSE COULD NOT BE DETERMINED. THE RX ACCULINK (PART 1011342-30, LOT 9091051), INDICATED IS BEING FILED UNDER A SEPARATE MFR NUMBER.

Description of Event or Problem · 1

DEVICE ISSUE: STENT #1 JUMPED. TIME OF DEVICE ISSUE: DURING THE PROCEDURE. ADVERSE EVENT: REQUIRED PLACEMENT OT AN ADDITIONAL UNPLANNED STENT. IT WAS REPORTED, VIA TRIAL, THAT DURING A LEFT COMMON CAROTID ARTERY STENTING PROCEDURE, THE RX ACCULINK STENT JUMPED DURING DEPLOYMENT AND LANDED DISTAL TO THE LESION. A SECOND RX ACCULINK STENT WAS PLACED, BUT WAS DEPLOYED PROXIMAL TO THE LESION. A THIRD NON-ABBOTT STENT WAS PLACED, SUCCESSFULLY, WITHIN THE LESION, AND OVERLAPPING THE TWO PREVIOUSLY PLACED STENTS; HOWEVER, PLACEMENT OF THE STENT RESULTED IN A SLIGHT TILTING OF THE DISTAL RX ACCULINK STENT. REPORTEDLY, THE STENT HAD THE POTENTIAL TO COMPROMISE FLOW IN THE LEFT INTERNAL CAROTID ARTERY (LICA), SO A 4TH RX ACCULINK STENT WAS PLACED IN THE LICA OVERLAPPING THE STENT AND CORRECTING THE ANGLE OF THE STENT. THERE WAS NO ADVERSE PT SEQUELA REPORTED. ONE DAY POST-PROCEDURE, THE PT WAS DISCHARGED TO HOME. ALTHOUGH REQUESTED, THERE WAS NO ADDITIONAL INFO PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RX ACCULINK CAROTID STENT SYSTEM NIM ABBOTT VASCULAR-VASCULAR SOLUTIONS NA 9082651

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention (1011649-55, LOT # 9061651)| EMBOLIC PROTECTION: RX ACCUNET| HEPARIN| STENT: PROTEGE GOS, EV3 EVER-FLEX| RX ACCULINK (1011342-30, 9091051)